| Literature DB >> 26066770 |
Donatella Vizza1, Anna Perri1, Giuseppina Toteda1, Simona Lupinacci1, Francesca Leone1, Paolo Gigliotti1, Danilo Lofaro1, Antonella La Russa1, Renzo Bonofiglio1.
Abstract
Clinical studies showed that renal expression and serum levels of nerve growth factor (NGF) are increased in renal diseases characterized by progressive fibrosis, a pathologic process in which TGF-β1 mediates most of the key events leading to tubular epithelial-mesenchymal transition (EMT). However, the pathogenic role of high NGF levels has not yet been elucidated. In this study, we found that in tubular renal cells, HK-2, NGF transcriptionally up-regulated TGF-β1 expression and secretion and enhanced cell motility by activating EMT markers via its receptors, TrkA and p75(NTR). Interestingly, we observed that TGF-β1-SMAD pathway activation and the up-regulation of EMT markers NGF-induced were both prevented when knockdown of TGF-β1 gene occurred and that the pretreatment with an antibody anti-NGF reversed the nuclear translocation of pSMAD3/SMAD4 complex. Collectively, our results demonstrated that NGF promotes renal fibrosis via TGF-β1-signaling activation, suggesting that in kidney diseases high NGF serum levels could contribute to worsen renal fibrosis.Entities:
Keywords: Epithelial–mesenchymal transition; TGF-β1; nerve growth factor; renal fibrosis; tubular renal cells
Mesh:
Substances:
Year: 2015 PMID: 26066770 DOI: 10.3109/08977194.2015.1054989
Source DB: PubMed Journal: Growth Factors ISSN: 0897-7194 Impact factor: 2.511